First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1206-1210

  Anckaert, Ellen ^a   Schiettecatte, Johan ^a   Sleurs, Elke ^a   Devroey, Paul ^b   Smitz, Johan ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLASMA PROTEIN;

ARTICLE; BLOOD ANALYSIS; DOWN SYNDROME; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; INFERTILITY; INFERTILITY THERAPY; PRIORITY JOURNAL; SCREENING;

ADULT; BELGIUM; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; HUMANS; INCIDENCE; INFERTILITY, FEMALE; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 52949115351     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.08.050     Document Type: Article

References (19)

1. Wald N.J., Rodeck C., Hackshaw A.K., Walters J., Chitty L., and Mackinson A.M. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10 (2003) 56-104
2. Malone F.D., Canick J.A., Ball R.H., Nyberg D.A., Comstock C.H., Bukowski R., et al. First- and second-trimester evaluation of risk (FASTER) research consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353 (2005) 2001-2011
3. Maymon R., and Jauniaux E. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod Biomed Online 4 (2002) 285-293
4. Wald N.J., White N., Morris J.K., Huttly W.J., and Canick J.A. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol 106 (1999) 1304-1306
5. Muller F., Dreux S., Lemeur A., Sault C., Desgres J., Bernard M.A., et al. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Prenat Diagn 23 (2003) 1073-1076
6. Rice J.D., McIntosh S.F., and Halstead A.C. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Prenat Diagn 25 (2005) 234-238
7. Bellver J., Lara C., Soares S.R., Ramirez A., Pellicer A., Remohi J., et al. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 20 (2005) 2623-2627
8. Raty R., Virtanen A., Koskinen P., Anttila L., Forsstrom J., Laitinen P., et al. Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome. Hum Reprod 17 (2002) 481-484
9. Hui P.W., Tang M.H., Lam Y.H., Ng E.H., Yeung W.S., and Ho P.C. Maternal serum hCG and alpha-fetoprotein levels in pregnancies conceived after IVF or ICSI with fresh and frozen-thawed embryos. Hum Reprod 18 (2003) 572-575
10. Orlandi F., Rossi C., Allegra A., Krantz D., Hallahan T., Orlandi E., et al. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22 (2002) 718-721
11. Maymon R., and Shulman A. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons. Hum Reprod 17 (2002) 1081-1085
12. Tul N., and Novak-Antolic Z. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn 26 (2006) 1206-1211
13. Wojdemann K.R., Larsen S.O., Shalmi A., Sundberg K., Christiansen M., and Tabor A. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 21 (2001) 563-565
14. Liao A.W., Heath V., Kametas N., Spencer K., and Nicolaides K.H. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 16 (2001) 1501-1504
15. Ghisoni L., Ferrazzi E., Castagna C., Levi Setti P.E., Masini A.C., and Pigni A. Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 24 (2003) S99-S103
16. Maymon R., and Shulman A. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 24 (2004) 125-129
17. Lambert-Messerlian G., Dugoff L., Vidaver J., Canick J.A., Malone F.D., Ball R.H., et al. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat Diagn 26 (2006) 672-678
18. Frendo J.L., Guibourdenche J., Pidoux G., Vidaud M., Luton D., Giovangrandi Y., et al. Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy. J Clin Endocrinol Metab 89 (2004) 727-732
19. Englert Y., Roger M., Belaisch-Allart J., Jondet M., Frydman R., and Testart J. Delayed appearance of plasmatic chorionic gonadotropin in pregnancies after in vitro fertilization and embryo transfer. Fertil Steril 42 (1984) 835-838